quin2 has been researched along with Leukemia, Myeloid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, H; Lu, JH; Ou, YX; Wei, YM; Zheng, RL | 1 |
| Lutz, F; Sasaki, T | 1 |
2 other study(ies) available for quin2 and Leukemia, Myeloid
| Article | Year |
|---|---|
Down-regulation of four arsenic antagonists on apoptosis and telomerase activity induced by arsenic trioxide in three myelocytic leukemia cell lines.
Topics: Acetylcysteine; Aminoquinolines; Antineoplastic Agents; Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Catalase; Down-Regulation; HL-60 Cells; Humans; K562 Cells; Leukemia, Myeloid; Oxides; Telomerase | 2001 |
Action of a cytotoxin from Pseudomonas aeruginosa on human leukemic cell lines. Increase in cell permeability to Ca2+ and Mn2+ and lack of stimulation of inositol lipid turnover.
Topics: Aminoquinolines; Calcium; Cell Line; Cell Membrane Permeability; Humans; Inositol Phosphates; Leukemia; Leukemia, Myeloid; Leukocidins; Manganese; Phytohemagglutinins; Spectrometry, Fluorescence; Sugar Phosphates; T-Lymphocytes | 1985 |